Medina-Murillo GR, Rodríguez-Medina U, Rodríguez-Wong U

Language: Spanish
References: 20
Page: 192-195
PDF size: 108.06 Kb.

ABSTRACT

Pyoderma gangrenosum is an extraintestinal manifestation of inflammatory bowel disease, this ulcerative disorder corresponds to a group of neutrophilic dermatoses. It is presented in 20% of patients with Crohn’s disease and in 5% of patients with ulcerative colitis, moreover 50% of all gangrenous pyoderma associated with inflammatory bowel disease. The first lines of treatment are systemic corticosteroids, but nowadays biological therapy with infliximab and adalimumab has shown good results.

REFERENCES

1. Gregory B, Ho V. Cutaneous manifestations of gastrointestinal disorders. Part II. J Am Acad Dermatol 1992; 26: 371-83.

2. Puig L, de Moragas J. Manifestaciones cutáneas de la enfermedad inflamatoria crónica idiopática del intestino. Piel 1987; 2: 512-8.

3. Medina-Murillo R, Rodríguez-Wong U. Manifestaciones cutáneas de las enfermedades inflamatorias intestinales. Rev Hosp Jua Mex 2007; 74(1): 11-5.

4. García B, Reyes E, García HL, Orozco-Topete R. Pioderma gangrenoso. Asociación con enfermedades sistémicas y evolución clínica en 14 pacientes. Dermatol Rev Mex 2000; 44: 1016.

5. Powell F, Collins S. Pyoderma gangrenosum. Clin Dermatol 2000; 18: 283-93.

6. Brunsting LA, Goeckerman WH, O’Leary PA. Pyoderma (echtyma) gangrenosum. Clinical and experimental observations in five cases ocurring in adults. Arch Dermatol Syphilol 1930; 22: 655-80.

7. Schwaegerle SM, Bergfeld WF, Senitzer D. Pyoderma gangrenosum: a review. J Am Acad Dermatol 1988; 18: 559-68.

8. Moschella SL. Pyoderma gangrenosum. Arch Dermatol 1967; 95: 121-3.

9. Newell LM, Malkinson F. Commentary: pyoderma gangrenosum. Arch Dermatol 1982; 118: 769-73.

10. Loeffel ED, Koya D. Cutaneous manifestations of gastrointestinal disease. Cutis 1978; 21: 852-61.

11. Samitz MH. Dermatological manifestations of gastrointestinal disease. En: Berk EL (ed.). Gastroenterology. Philadelphia: WB Saunders; 1985, p. 285-315.

12. Perry HO, Brunsting LA. Pyoderma gangrenosum. Arch Dermatol 1957; 75: 380.

13. Hickman JG, Lazarus GS. Pyoderma gangrenosum: new concepts in etiology and treatment. En: Moschella SL (ed.). Dermatology Update. Reviews for Physians. New York: Elsevier; 1979, p. 325.

14. Thornton JR, Teague RH, Low-Beer TS, Read E. Pyoderma gangrenosum and ulcerative colitis. Gut 1980; 21: 247-8.

15. Argüelles-Arias F, Castro-Laria L, Lobatón T, Aguas-Peris M, Rojas- Feria M, Barreiro-de Acosta M, et al. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease. Dig Dis Sci 2013; 58(10): 2949-54.

16. Levitt MD, Ritchie JK, Lennard-Jones JE, Phillips RK. Pyoderma gangrenosum in inflammatory bowel disease. Br J Surg 1991; 78(6): 676-8.

17. Ampuero J, Rojas-Feria M, Castro-Fernández M, Cano C, Romero- Gómez M. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease. J Gastroenterol Hepatol 2013. Doi: 10.1111/jgh.12352.

18. Guo H, Zhang L, An Q, Yang ZH, Li B, Gao XH, Li JH. Pyoderma gangrenosum associated with ulcerative colitis and psoriasis. Chin Med J 2013; 126(9): 1798.

19. Kiran RP, O’Brien-Ermlich B, Achkar JP, Fazio VW, Delaney CP. Management of peristomal pyoderma gangrenosum. Dis Colon Rectum 2005; 48(7): 1397-403.

20. Funayama Y, Kumagai E, Takahashi K, Fukushima K, Sasaki I. Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease. Dis Colon Rectum 2009; 52(2): 311-4.